Clinical Trials
4 trialsNCT07612007 2026-06-01
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Mayo Clinic
Phase 2 Not yet recruiting
NCT04597710 2026-05-29
Precision1
Perspectum
Completed
NCT07581769 2026-05-14
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
First Affiliated Hospital, Sun Yat-Sen University
Active not recruiting
NCT07587216 2026-05-14
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Tongji Hospital
Recruiting